Cary Street Partners Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Sell |
|
|||||
|
2025
Q1 | $236K | Buy |
|
|||||
|
2024
Q4 | $261K | Sell |
|
|||||
|
2024
Q3 | $4.28M | Sell |
|
|||||
|
2024
Q2 | $4.29M | Buy |
|
|||||
|
2024
Q1 | $3.26M | Buy |
|
|||||
|
2023
Q4 | $2.71M | Buy |
|
|||||
|
2023
Q3 | $2.19M | Buy |
|
|||||
|
2023
Q2 | $1.59M | Buy |
|
|||||
|
2023
Q1 | $207K | Buy |
|
|||||
|
2022
Q4 | $80.8K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $113K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $37K | Buy |
|